Skip to content
Science in Public
  • About usExpand
    • Our team
    • Our clients
    • Our portfolio
  • Our servicesExpand
    • Writing and editing
    • Communication support
    • One-to-one consulting
    • Video production
    • Media for conferences
  • Media Training
  • Media releases
  • National Science Week
  • Newsletters
Contact
Science in Public
  • Melbourne Global

    Case Study: New rotavirus vaccine enters manufacturing

    14 December, 201814 December, 2018

    Bio Farma, Indonesia’s national vaccine company, is completing a phase 1 trial of a new rotavirus vaccine invented in Melbourne and has started pilot manufacture of the vaccine. Licencing trials are next, followed hopefully by release of the new vaccine in 2021. The project is the culmination of a 42-year partnership between Melbourne and Gadjah…

    Read More Case Study: New rotavirus vaccine enters manufacturingContinue

  • New rotavirus vaccine could benefit millions of children
    Media releases

    New rotavirus vaccine could benefit millions of children

    22 February, 201817 October, 2019

    A rotavirus vaccine that can be given days after birth has been developed by Australian and Indonesian researchers. Rotavirus is the common cause  of severe diarrhoea and a killer of approximately 215,000 children under five globally each year. The oral vaccine, called RV3-BB, was given in three single doses, the first within five days of birth….

    Read More New rotavirus vaccine could benefit millions of childrenContinue

© 2026 Science in Public - WordPress Theme by Kadence WP

Linkedin Bluesky Facebook Twitter
  • About us
    • Our team
    • Our clients
    • Our portfolio
  • Our services
    • Writing and editing
    • Communication support
    • One-to-one consulting
    • Video production
    • Media for conferences
  • Media Training
  • Media releases
  • National Science Week
  • Newsletters
Search